Navigation Links
Drug-Eluting Stents Market 2015-2022 - Global Strategic Business Report 2017 - High Diabetes Incidence Worldwide Drives Demand for Cardiac Surgery and Stents - Research and Markets
Date:2/17/2017

DUBLIN, Feb 17, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Drug-Eluting Stents - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Drug-Eluting Stents in US$ Million.

The report profiles 35 companies including many key and niche players such as

  • Abbott Laboratories (US)                                       
  • AlviMedica (Turkey)                                            
  • Arterius Limited (UK)                                          
  • B. Braun Melsungen AG (Germany)                                
  • Biosensors International Group, Ltd. (Singapore)               
  • Shandong JW Medical Systems LTD. (China)                       
  • Biotronik SE & Co. KG (Germany)                                
  • Boston Scientific Corporation (US)                             
  • Cook Medical Inc. (US)                                         
  • Elixir Medical Corp. (US)                                      
  • KYOTO MEDICAL PLANNING Co., Ltd. (Japan)                       
  • Lepu Medical Technology (Beijing) Co., Ltd. (China)            
  • Medtronic plc (Republic of Ireland)                            
  • Micell Technologies, Inc. (US)                                 
  • Opto Circuits (India) Ltd (India)                              
  • Eurocor GmbH (Germany)                                         
  • OrbusNeich Medical Company Limited (Hong Kong)                 
  • QualiMed (Germany)                                             
  • Shanghai MicroPort Medical (Group) Co., Ltd. (China)           
  • Sino Medical Sciences Technology Inc. (China)                  
  • STENTYS SA (France)                                            
  • Terumo Corporation (Japan)   

Key Topics Covered:

1. Industry Overview                                           

2. Macro Growth Drivers                                        

  • Aging - A Key Market Driver                                    
  • Global Aging Population Demographic Statistics: Key Opportunity Indicator                                          
  • High Diabetes Incidence Worldwide Drives Demand for Cardiac Surgery and Stents                             

3. Coronary Stenting - An Insight                              

  1. Cardiovascular Diseases - A Brief Description                  
  2. Coronary Heart Disease                                         
  3. Treatment Options for Coronary Artery Disease                  
  4. Percutaneous Transluminal Coronary Angioplasty (PTCA)          
  5. Coronary Artery Bypass Graft (CABG)                            
  6. Coronary Stenting                                              
  7. How is Coronary Stenting Performed - Procedure                 
  8. Risks and Problems Associated with Placing a Stent             
  9. Restenosis - A Major Challenge                                 
  10. Cost and Price Economics of DES                                
  11. Cost Evaluation of DES                                         
  12. Impact of DES on Indirect Costs                                

4. Product Launches & Approvals                                

  • MicroPort Medical Receives Marketing Approval in Argentina for Firehawk® DES                                                  
  • MicroPort Medical's Firehawk® DES Receives Marketing Approval in Brazil                                                      
  • Biotronik Launches Biostem Clinical Trial for Orsiro Hybrid DES
  • Boston Scientific's Eluvia DES System Receives CE Mark         
  • STENTYS Enters into Commercialization Agreements in Europe for below-the-knee arterial DES                                    
  • Medtronic Launches Expanded Sizes of Onyx DES and Expands Indications                                                    
  • Svelte Medical Launches SLENDER Coronary Stent System in Europe
  • Boston Scientific Receives FDA Approval for SYNERGY DES System
  • Medtronic Launches Resolute Onyx DES in India                 

5. Recent Industry Activity                                    

  • Cordis Enters into Coronary Stent Sales Agreement with Biosensors International                                       
  • MicroPort Scientific Acquires DES Assets and Intellectual Property from Cordis                                           

6. Focus On Select Global Players                          

7. Global Market Perspective   

Total Companies Profiled: 35 (including Divisions/Subsidiaries - 40)

- The United States (16)

- Japan (2)

- Europe (20)

- France (1)

- Germany (4)

- The United Kingdom (2)

- Rest of Europe (3)

- Asia-Pacific (Excluding Japan) (10)

- Middle East (1)

- Africa (1)

For more information about this report visit http://www.researchandmarkets.com/research/mmkjjl/drugeluting

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/drug-eluting-stents-market-2015-2022---global-strategic-business-report-2017---high-diabetes-incidence-worldwide-drives-demand-for-cardiac-surgery-and-stents---research-and-markets-300409483.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. The Global Market for Novel Peripheral and Neurointerventional Therapeutic Systems Set to Reach $1.5B by 2018 Driven Largely by Explosive Growth in the Drug-Eluting Balloon Market
2. Biodegradable Stents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
3. Global Coronary Stents Market : Analysis By Segment, By Region, By Country
4. Coronary Stents Market to Grow at 3.05% CAGR and Bio-resorbable Stents Drives Growth by 2021
5. Bioabsorbable Stents Market Worth 2.4 Billion USD by 2021
6. India Coronary Stents Market to Reach US$ 531 Mn by 2016-end, says Future Market Insights (FMI)
7. Peripheral Stents Taking on New Caseload, Markets, According to New MedMarket Diligence Report
8. Global Non-Vascular Stents Market Assessment & Forecast: 2015-2019
9. Global Vascular and Non-Vascular Stents Market 2015-2021 - Threats for the Stents Market Include Reduced Reimbursement, Alternative Procedures and Stringent Regulations for Stent Approval
10. Global Glaucoma Surgery Devices Market to 2019 by Type (Glaucoma Drainage, Implants & Stents, Glaucoma Laser Devices, Glaucoma Systems), by End User (Private Eye Clinics, Hospitals), by Geography
11. Intracranial Stents - 2015-2020 Global Strategic Business Report: Growing Importance of Intracranial Stents in Neurovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):